Login / Signup

Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply.

Ammar Hassanzadeh KeshteliKaren L MadsenRupasri MandalGuy E BoeckxstaensPremysl BercikGiada De PalmaDavid E ReedDavid WishartStephen VannerLevinus A Dieleman
Published in: Alimentary pharmacology & therapeutics (2020)
Keyphrases
  • irritable bowel syndrome
  • ulcerative colitis
  • squamous cell carcinoma
  • locally advanced
  • disease activity
  • radiation therapy